Effects of Dexmedetomidine During IRE Procedures for Solid Tumours

• Status: Completed
• Trial end date: 2015-09-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of the study is to evaluate effects of dexmedetomidine on anaesthesia during IRE procedures for solid tumours

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Uppsala University Hospital
• Treatments: Anesthetics; Dexmedetomidine

Criteria

Inclusion Criteria:

1. liver or/and pancreas cancer for which IRE procedure is planned

2. signed informed consent form

Exclusion Criteria:

1. patient refusal

2. pregnancy

3. known allergy to dexmedetomidine or other anaesthesia drugs

4. atrioventricular block grade II or III or other significant cardiac conduction disturbance

5. stroke

6. low blood pressure not responding to treatment